Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 5 Ovarian Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1 Non-alcoholic Fatty Liver Disease 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephritis 1 Neoplasm Metastasis 1 Multiple Sclerosis 1 Mucopolysaccharidosis I 1 Melanoma 1

Interventions

lutetium Lu 177 dotatate 5 Data Collection 3 telotristat ethyl 2 Somatostatin 2 Positron-Emission Tomography 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Drug Therapy 2 Biopsy 2 surufatinib 1 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Quality of Life 1 Plastic Surgery Procedures 1 Phlebotomy 1 Patient Reported Outcome Measures 1 Octreotide 1 Molecular Diagnostic Techniques 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neuroendocrine Tumors × Phlebotomy × Clear all

NCT03130205 2017-08-25

PROGRESS

Uppsala University

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡